Patients with clinically isolated syndromes (CIS) are prone to develop multiple sclerosis (MS). The randomized, placebo-controlled CHAMPS trial found early treatment with interferon -1a to be ...
Rebif (interferon beta-1a) is a prescription drug that treats certain types of multiple sclerosis. Rebif’s cost may depend on factors such as your dosage, whether ...
MS typically appears in young adulthood, but 3% to 5% of cases have an onset in early childhood or adolescence. No disease-modifying therapies have FDA approval for persons younger than 18 years of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback